Amsterdam, North Holland, Netherlands
Pluvia Biotech is a spin-out from the University of Bergen (Norway) dedicated to developing oral pharmacological chaperones for the treatment of Phenylketonuria (PKU). Through pioneering research and development, Pluvia Biotech aims to provide PKU patients with the opportunity to live life without the dietary constraints imposed by the condition.
GENESIS Pharma is a biopharmaceutical company specializing in the commercialization of innovative pharmaceutical products for serious and rare diseases in Central and Eastern Europe.
Khondrion is a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease.
The Termeer Institute supports and empowers young life science innovators through values-driven leadership programming including mentorship, network development and thought leadership to advance groundbreaking, patient-centric solutions.